Company intelligence / Profile preview

ALZA Corporation

Mountain View*, California, USAalza.cz ↗
Ownership
Private
Employees
~10000
Development stage
Commercial
01

Overview

ALZA was a pioneer in drug delivery technologies and brought over twenty prescription pharmaceutical products to market. Its platforms enabled controlled-release and transdermal therapies that improved efficacy and patient compliance. Many of its products became blockbusters through partnerships or licensing to major pharma companies. The company was acquired by Johnson & Johnson in May 2001 for $10.5 billion.[1][3]

Therapeutic areas
PsychiatryCardiovascularUrologyEndocrinologyOtherOncology
Modalities
Transdermal patches (e.g., Nicoderm, Duragesic)Osmotic oral systems (OROS)Depot injections (Alzamer Depot)Implants (DUROS implant)Liposomal formulations (Stealth liposomal, via Sequus acquisition)
Industry
Biotech
02

Drug pipeline

3 assets

metformin

Commercial
Indications
Type 2 diabetes

2 more assets in the full pipeline.

Request access →
03

Partnerships

Pfizer *(Procardia XL, Glucotrol XL)*Bayer *(Viadur)*G.D. Searle *(Covera HS)*Ciba-Geigy/CIBA Consumer Pharmaceuticals *(Efidac/24)*Marion Merrell Dow *(Nicoderm)*[2][8]

Beyond the preview

Go deeper on ALZA Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALZA Corporation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call